Nabumetone
- Product NDC
- 55700-845
- 11-digit product format
- 557000845
- Labeler code
- 55700
- Product ID
- 55700-845_273dcba6-29a0-47f9-83b4-04d1e692232e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nabumetone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Quality Care Products, LLC
- Application
- ANDA078420
- Marketing category
- ANDA
- Marketing start
- 2020-02-28
- Marketing end
- 2027-03-31
- Substance
- NABUMETONE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Nabumetone
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| NABUMETONE | 500 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | LW0TIW155Z |
| Rxcui | 311892 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 55700-845-30 | Nabumetone | 30 in 1 BOTTLE | TABLET | 30 | | 6 |
| 55700-845-60 | Nabumetone | 60 in 1 BOTTLE | TABLET | 60 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 55700-845 | NABUMETONE TABLET [QUALITY CARE PRODUCTS, LLC] | 6 | Current NDC, Legacy NDC, 2 package rows | 20241220_065fdacc-739e-4b46-bebc-044b5c11bbbb.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55700-845-30 | 55700084530 | 30 TABLET in 1 BOTTLE (55700-845-30) | 30 tablet | 2020-02-28 | 0000-00-00 | No | No | Current |
| 55700-845-60 | 55700084560 | 60 TABLET in 1 BOTTLE (55700-845-60) | 60 tablet | 2020-02-28 | 2027-03-31 | No | No | Current |